The launch and rapid growth of Goodwin’s Paris office with its experienced private equity and tax teams are featured in an article by French publication Private Equity Magazine.
To read the full article in French click here and in English click here.
Related Content
- InsightJuly 16, 2025
What’s on the Horizon for Aerospace and Defense? A Download Après the Paris Air Show/Le Bourget
- AlertJuly 7, 2025
One Big Beautiful Bill Act – Tax Highlights related to Research and Experimental Expenditures, Qualified Small Business Stock and Business Interest Expense Deductions
- InsightJune 26, 2025
How to Write an Effective Public Benefit Report
- InsightJune 23, 2025
“They Will Thank Me in the Long Run”: Court of Appeal Considers Good Faith Obligations and Fiduciary Duties of Directors in Relation to Shareholder Exit Provisions
- AlertJune 11, 2025
Oregon Governor Signs Law Aggressively Restricting Private Equity Investment in Medical Practices
- InsightMay 27, 2025
Crafting a Competitive LOI in Lower Middle Market M&A
- AlertApril 24, 2025
Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare
- InsightApril 23, 2025
Five Trends Reshaping Pharmaceutical Manufacturing Partnerships
- Press ReleaseJuly 10, 2025
Parquest to Sell Sopral to IPN
- Press Release9 July 2025
Goodwin Advises GREENPEAK Partners Portfolio Company encoviva on the Acquisition Financing of ING.FTG
- Press Release8 July 2025
Goodwin Strengthens its European Private Equity Platform with Debt Finance Partner Tom Roberts
- Awards and RankingsJuly 7, 2025
Goodwin Is Number One Law Firm for Global M&A for H1 2025
- Press ReleaseJuly 3, 2025
Triton to Acquire Prenax
- Press ReleaseJuly 3, 2025
Goodwin Advises INTEC on Financing for the Acquisition of a Majority Stake in Three Companies of ARBOR Group
- Awards and RankingsJuly 2, 2025
Katherine Baudistel Recognized by Los Angeles Business Journal’s 2025 Leaders of Influence in Private Equity
- Press ReleaseJuly 1, 2025
Goodwin Advised Landmark Bio in Acquisition by Artis BioSolutions to Expand Manufacturing and Commercialization of Advanced Therapies